Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01580384 · ClinicalTrials.gov registry record

A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome

A clinical trial of Down Syndrome, sponsored by Hoffmann-La Roche.

Completed
Registry status
90
Enrollment target
12
Study locations

NCT01580384 is a study of Down Syndrome that has completed, run by Hoffmann-La Roche. The registered enrollment target is 90 participants, below the 2,470-participant average among 54 other Down Syndrome trials with a reported enrollment target (96% lower). The trial reports 12 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01580384, a study of Down Syndrome, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
90 participants
Enrollment target
12
Study locations

Study Summary

This non-drug, longitudinal, multi-center, multi-national study will evaluate the suitability of neurocognitive tests and functioning scales for the measurement of cognitive and functioning changes in individuals with Down Syndrome. Tests will be administered at clinic visits in Weeks 1, (4) and 24. The duration of the study for each individual will be between 24 and 27 weeks.

Conditions Studied

Study Locations (12)

Other

  • - Ciudad Autonoma de Bs As
  • - Ciudad de Buenos Aires
  • - Paris
  • - Saint-Etienne
  • - London
  • - Redruth

Arizona

  • - Tucson

North Carolina

  • - Durham

Nova Scotia

  • - Kentville

Lazio

  • - Rome

Sicily

  • - Palermo

Barcelona

  • - Barcelona

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2012-02
Est. Completion 2014-01

Sponsor

Hoffmann-La Roche

909 total trials

What the Registry Record Tells You About NCT01580384

The ClinicalTrials.gov registry entry for NCT01580384 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,470-participant average among 54 other Down Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT01580384 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Other, Arizona, North Carolina.

Frequently Asked Questions

What is clinical trial NCT01580384 about?

NCT01580384 is a clinical study titled "A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome". This non-drug, longitudinal, multi-center, multi-national study will evaluate the suitability of neurocognitive tests and functioning scales for the measurement of cognitive and functioning changes in individuals with Down Syndrome. Tests will be administered at clinic visits in Weeks 1, (4) and 24....

What is the current status of trial NCT01580384?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2012-02. Estimated completion is 2014-01.

What conditions does trial NCT01580384 study?

This clinical trial studies the following conditions: Down Syndrome.

Who is sponsoring clinical trial NCT01580384?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01580384 being conducted?

This trial has 12 study locations across Arizona, North Carolina, Nova Scotia, Lazio, Sicily. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.